Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin for liver enzyme changes in opium poisoning
IRCT20220305054196N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of curcumin in Opium poisoning, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Change in liver enzyme levels. Started Mar 2023; status: completed.
02
Drugs
curcumin
03
Conditions
Opium poisoning
Beyond the preview
Go deeper on IRCT20220305054196N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220305054196N2.